Goldman Sachs’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,201,089
| Closed | -$75.8M | – | 4884 |
|
|
2020
Q3 | $75.8M | Buy |
2,201,089
+1,889,720
| +607% | +$65.1M | 0.02% | 637 |
|
|
2020
Q2 | $5.2M | Sell |
311,369
-134,799
| -30% | -$2.25M | ﹤0.01% | 2321 |
|
|
2020
Q1 | $6.43M | Buy |
446,168
+142,213
| +47% | +$2.05M | ﹤0.01% | 2088 |
|
|
2019
Q4 | $10.2M | Buy |
303,955
+101,833
| +50% | +$3.41M | ﹤0.01% | 2030 |
|
|
2019
Q3 | $4.23M | Sell |
202,122
-105,622
| -34% | -$2.21M | ﹤0.01% | 2421 |
|
|
2019
Q2 | $6.41M | Sell |
307,744
-17,627
| -5% | -$367K | ﹤0.01% | 2169 |
|
|
2019
Q1 | $7.27M | Buy |
325,371
+135,964
| +72% | +$3.04M | ﹤0.01% | 2215 |
|
|
2018
Q4 | $4.53M | Sell |
189,407
-71,080
| -27% | -$1.7M | ﹤0.01% | 2394 |
|
|
2018
Q3 | $7.11M | Buy |
260,487
+41,716
| +19% | +$1.14M | ﹤0.01% | 2241 |
|
|
2018
Q2 | $5.88M | Buy |
218,771
+30,336
| +16% | +$816K | ﹤0.01% | 2320 |
|
|
2018
Q1 | $6M | Buy |
188,435
+107,557
| +133% | +$3.42M | ﹤0.01% | 2233 |
|
|
2017
Q4 | $3.06M | Sell |
80,878
-166,498
| -67% | -$6.3M | ﹤0.01% | 2583 |
|
|
2017
Q3 | $6.13M | Buy |
247,376
+19,999
| +9% | +$496K | ﹤0.01% | 2233 |
|
|
2017
Q2 | $4.68M | Buy |
227,377
+132,603
| +140% | +$2.73M | ﹤0.01% | 2317 |
|
|
2017
Q1 | $2.06M | Buy |
94,774
+52,558
| +124% | +$1.14M | ﹤0.01% | 2721 |
|
|
2016
Q4 | $863K | Buy |
+42,216
| New | +$863K | ﹤0.01% | 3165 |
|
|
2016
Q2 | – | Sell |
-15,639
| Closed | -$212K | – | 4701 |
|
|
2016
Q1 | $212K | Buy |
+15,639
| New | +$212K | ﹤0.01% | 3739 |
|
|
2015
Q4 | – | Sell |
-15,482
| Closed | -$392K | – | 4682 |
|
|
2015
Q3 | $392K | Buy |
+15,482
| New | +$392K | ﹤0.01% | 3450 |
|